MEDICO REMEDIES Financial Statement Analysis
|
||
The Revenues of MEDICO REMEDIES have increased by 3.19% YoY .
The Earnings Per Share (EPS) of MEDICO REMEDIES has increased by 14.94 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
MEDICO REMEDIES Last 5 Annual Financial Results
[BOM: 540937|NSE : MEDICO]
Standalone | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
---|---|---|---|---|---|
Revenues | ₹145 Cr | ₹140 Cr | ₹121 Cr | ₹122 Cr | ₹89 Cr |
Expenses | ₹132 Cr | ₹131 Cr | ₹114 Cr | ₹117 Cr | ₹86 Cr |
Operating Profit (Excl OI) | ₹13 Cr | ₹9.48 Cr | ₹7.34 Cr | ₹5.24 Cr | ₹2.84 Cr |
Other Income | ₹2.13 Cr | ₹4.09 Cr | ₹2.03 Cr | ₹1.03 Cr | ₹2.10 Cr |
Interest | ₹0.82 Cr | ₹0.75 Cr | ₹0.66 Cr | ₹0.92 Cr | ₹1.06 Cr |
Depreciation | ₹2.88 Cr | ₹2.72 Cr | ₹2.22 Cr | ₹1.65 Cr | ₹1.66 Cr |
Profit Before Tax | ₹11 Cr | ₹10 Cr | ₹6.48 Cr | ₹3.70 Cr | ₹2.22 Cr |
Profit After Tax | ₹8.29 Cr | ₹7.24 Cr | ₹4.81 Cr | ₹2.59 Cr | ₹1.63 Cr |
Earnings Per Share (Rs) | ₹1.00 | ₹0.87 | ₹2.90 | ₹6.24 | ₹3.93 |
PAT Margin (%) | 5.72 | 5.16 | 3.98 | 2.12 | 1.84 |
ROE(%) | 17.23 | 18.01 | 13.94 | 8.31 | 5.61 |
ROCE(%) | 21.90 | 21.88 | 15.09 | 10.13 | 7.66 |
Total Debt/Equity(x) | 0.13 | 0.18 | 0.29 | 0.46 | 0.46 |
Key Financials |
||
Market Cap | : | ₹ 645.2 Cr |
Revenue (TTM) | : | ₹ 151.0 Cr |
Net Profit(TTM) | : | ₹ 8.9 Cr |
EPS (TTM) | : | ₹ 1.1 |
P/E (TTM) | : | 72.9 |
Industry Peers & Returns | 1W | 1M | 1Y |
MEDICO REMEDIES | 4.3% | 28% | -8.3% |
SUN PHARMACEUTICAL INDUSTRIES | -0% | -4.6% | 18.9% |
CIPLA | 2.4% | -1.1% | 0.8% |
DR REDDYS LABORATORIES | 2.6% | -9.9% | -0.4% |
ZYDUS LIFESCIENCES | 3.6% | -0.1% | 22.7% |
DIVIS LABORATORIES | 8.8% | 5.1% | 64.4% |
MANKIND PHARMA | -0.1% | -12.4% | 18.5% |
TORRENT PHARMACEUTICALS | -1.4% | -4.9% | 19.3% |
LUPIN | 6.4% | -2.9% | 38.4% |
MEDICO REMEDIES Revenues
[BOM: 540937|NSE : MEDICO]
Y-o-Y | 3.19 % |
5 Yr CAGR | 13.08 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2024 | ₹145 Cr | 3.19 | |
Mar2023 | ₹140 Cr | 16.04 | |
Mar2022 | ₹121 Cr | -1.12 | |
Mar2021 | ₹122 Cr | 38.08 | |
Mar2020 | ₹89 Cr | - |
MEDICO REMEDIES Operating Profit
[BOM: 540937|NSE : MEDICO]
Y-o-Y | 36.16 % |
5 Yr CAGR | 46.00 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2024 | ₹13 Cr | 36.16 | |
Mar2023 | ₹9.48 Cr | 29.26 | |
Mar2022 | ₹7.34 Cr | 39.98 | |
Mar2021 | ₹5.24 Cr | 84.44 | |
Mar2020 | ₹2.84 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | 32.00 % |
5 Yr CAGR | 29.08 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2024 | 8.91% | 32.00 | |
Mar2023 | 6.75% | 11.39 | |
Mar2022 | 6.06% | 41.59 | |
Mar2021 | 4.28% | 33.33 | |
Mar2020 | 3.21% | - |
MEDICO REMEDIES Profit After Tax
[BOM: 540937|NSE : MEDICO]
Y-o-Y | 14.48 % |
5 Yr CAGR | 50.18 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2024 | ₹8.29 Cr | 14.48 | |
Mar2023 | ₹7.24 Cr | 50.50 | |
Mar2022 | ₹4.81 Cr | 85.79 | |
Mar2021 | ₹2.59 Cr | 58.90 | |
Mar2020 | ₹1.63 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | 10.85 % |
5 Yr CAGR | 32.78 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2024 | 5.72 % | 10.85 | |
Mar2023 | 5.16 % | 29.65 | |
Mar2022 | 3.98 % | 87.74 | |
Mar2021 | 2.12 % | 15.22 | |
Mar2020 | 1.84 % | - |
MEDICO REMEDIES Earnings Per Share (EPS)
[BOM: 540937|NSE : MEDICO]
Y-o-Y | 14.94 % |
5 Yr CAGR | -28.98 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2024 | ₹1.00 | 14.94 | |
Mar2023 | ₹0.87 | -70.00 | |
Mar2022 | ₹2.90 | -53.53 | |
Mar2021 | ₹6.24 | 58.78 | |
Mar2020 | ₹3.93 | - |
MEDICO REMEDIES Return on Capital Employed (ROCE)
[BOM: 540937|NSE : MEDICO]
Y-o-Y | 0.09 % |
5 Yr CAGR | 30.03 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2024 | 21.9% | 0.09 | |
Mar2023 | 21.88% | 45.00 | |
Mar2022 | 15.09% | 48.96 | |
Mar2021 | 10.13% | 32.25 | |
Mar2020 | 7.66% | - |
MEDICO REMEDIES Share Price vs Sensex
Current Share Price | : | ₹77.7 |
Current MarketCap | : | ₹ 645.2 Cr |
Updated EOD on | : | Feb 06,2025 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MEDICO REMEDIES | 4.3% |
28% |
-8.3% |
SENSEX | 0.7% |
-0.1% |
8.8% |
MEDICO REMEDIES related INDICES
You may also like the below Video Courses
FAQ about MEDICO REMEDIES Financials
How the annual revenues of MEDICO REMEDIES have changed ?
The Revenues of MEDICO REMEDIES have increased by 3.19% YoY .
How the Earnings per Share (EPS) of MEDICO REMEDIES have changed?
The Earnings Per Share (EPS) of MEDICO REMEDIES has increased by 14.94 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs